About CPIVC

Council for the Promotion of International Vaccine Cooperation (CPIVC) of China Association for Vaccines (CAV)

The Council for the Promotion of International Vaccine Cooperation (CPIVC) of China Association for Vaccines (CAV), as a branch of China Association for Vaccines (CAV), its members include experts and scholars, enterprises, institutions and social agencies from the fields of vaccine research and development (R&D), vaccine production quality control, vaccine related regulation, disease prevention and control, public health, and immunization program management and clinical medicine.

As more vaccines manufactured in China are introduced internationally, it is important for enterprises to have a timely understanding of R&D progress, international regulatory trends & market demand. This will help Chinese companies to formulate their R&D strategy, capacity planning, and strategic marketing plans, and to help synergize their independent and collaborative activities to improve their capacity for innovative research. 

With the vision and mission of leading the development of the global vaccine industry and contributing to global health, CPIVC CAV is committed to building a comprehensive global service platform for academic exchange and industry cooperation in the vaccine sector, aiming to: 

  • promote the development of the vaccine industry and related biological products globally, 
  • enhance scientific and technological innovation, 
  • strengthen international cooperation, and  
  • safeguard global health. 

Core business of CPIVC CAV :

  1. provide international exchange and cooperation services,
  2. conduct global market analysis and provide research reports,
  3. provide industry analysis reports and consulting services,
  4. hold conferences and events, and
  5. provide training and coaching.

Through organizing activities and conducting policy advocacy, CPIVC CAV builds information sharing platforms for the domestic and global vaccine industry and makes full use of resources to promote international cooperation. CPIVC CAV also promotes the implementation of industry-relevant policies and regulations via strengthening communication and coordination with the government. CPIVC CAV serves to support and safeguard the Healthy China 2030 strategy and build a friendly international ecosystem for the vaccine industry development.

Members of CPIVC CAV include universities, research institutes, national and provincial CDCs, relevant health administration agencies, drug regulatory agencies, vaccine and biological products manufacturers and suppliers, and international organizations. CPIVC CAV works closely with the Bill & Melinda Gates Foundation (BMGF) and PATH in strengthening international exchange and cooperation for the development of vaccine innovation and technologies.

CPIVC CAV operates on a committee system, which consists of the chairman, vice-chairmen, standing members, secretary general, and members. Currently, there are approximately 67 members in CPIVC CAV. It has full-time coordinators and project managers responsible for daily operation.

使命宣言

全球疫苗行业的发展对全球健康具有重要意义。

自新冠疫情大流行暴发以来，疫苗在保障全球健康方面的作用日益明显。然而，全球疫苗供应经常被诸如贸易壁垒、出口限制和生产能力缺乏等因素打乱，影响着世界各地人民的健康和福祉。世界亟需通过疫苗供应多元化来改善供应现状，以及通过促进行业发展来支持疫苗创新。

中国的疫苗研发、生产和监管者已经证明，其有潜力成为全球疫苗领域中更加重要的一员。但它们仍然面临重重障碍，需要通过更有效的国际合作来解决。

新冠疫情是一场灾难。但它对于中国的疫苗行业及所有参与者来说也是一个机遇，为疫苗厂商进入国际市场开辟了新的途径。然而中外双方对现存机会和技术局限的理解还比较局限，这体现出加强沟通与合作的必要性。国际疫苗合作需要更加紧密，从而促进中国和全球疫苗行业的发展，以及满足世界需求和守卫全球健康。

国际疫苗合作促进分会作为一个平台，旨在促进中外疫苗领域利益相关方的合作。

为实现这一目标，国际疫苗合作促进分会具有三重任务：首先，提升中外相关方的共同认识，为中国以新兴疫苗供应者身份进入全球疫苗市场提供咨询服务；其次，建立一个可以连接各相关方的平台，通过举办学术交流和产业合作为行业进步提供机会；最后，倡导更有利的政策，促进高质量的中国疫苗供应全球市场。

国际合作是疫苗行业进步的动力。我们真诚邀请您加入我们，共同引领全球疫苗行业发展，构筑人类卫生健康共同体。

Contact us

  • Office: Room 443, Building 6, Huihuang International Center, Shangdi 10th Avenue, Haidian District, Beijing
  • E-mail: fenhui_cpivc@cav.org.cn